NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced the appointment of Vivek Reddy, M.D., as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of its ...
Evaluation of primary aldosteronism testing in hypertensive patients with SLE in a tertiary hospital
S L E is a chronic multisystem autoimmune disease in which cardiovascular disease is a leading cause of mortality, with a ...
Understand the nurse’s role in managing hypertension and helping patients manage their blood pressure to reduce the risk of ...
4d
Migraine Again on MSNWhat Is Aimovig for Migraine? Key Facts to Know About This Preventive TreatmentLearn how Aimovig for migraine works, how well it works, what to know before starting, and its possible side effects. Experts and community members also weigh in about their experiences with Aimovig.
Frailty nurse specialist Linda Nazarko advises on what nurses in general practice need to be aware of when reviewing and ...
Jon Congleton; Chief Executive Officer, Director; Mineralys Therapeutics Inc. David Rodman; Chief Medical Officer ...
CEO Jon Congleton highlighted the company's focus on advancing its pivotal trials for lorundrostat, targeting dysregulated aldosterone in patients with uncontrolled and resistant hypertension. He ...
Primary aldosteronism treatment response was associated with higher plasma renin activity and serum potassium levels and lower aldosterone.
Anticipate topline data from pivotal Advance-HTN trial in March 2025 and pivotal Phase 3 Launch-HTN trial in mid first half of 2025 – – Completed enrollment in Explore-CKD Phase 2 trial and anticipate ...
MANP was originally discovered by John C. Burnett Jr., MD, Director of the Cardiorenal Research Laboratory at Mayo Clinic. E-Star and Mayo Clinic entered into a worldwide exclusive license agreement ...
If you or someone you know is living with AUD, many treatment options are available. A doctor can help you choose the best one for you. They may recommend detoxification, medication, relapse ...
The aim of this study was to perform a persistencebased pharmacoeconomic evaluation of patients receiving antihypertensive drug treatment. Specific objectives were represented by measuring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results